-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
In recent years, the development of Chinese herbal medicine industry has always attracted national attenti.
In order to promote the high-quality development of the Chinese herbal medicine industry, the state has issued a series of policies and measures that are being introduc.
For example, in March this year, the "Quality Management Standards for the Production of Chinese Herbal Medicines" (Chinese Herbal Medicine GAP), which was researched and formulated by the State Food and Drug Administration, the Ministry of Agriculture and Rural Affairs, the State Forestry and Grass Administration, and the State Administration of Traditional Chinese Medicine, proposed that it will encourage Chinese herbal medicine production enterprises, Traditional Chinese medicine production enterprises such as the holder of the marketing license for proprietary Chinese medicines shall establish themselves in the production areas of Chinese herbal medicines, and jointly build Chinese herbal medicine production enterprises and production bases that comply with this specification, and extend the drug quality management system to the production areas of Chinese herbal medicin.
Recently, the "14th Five-Year Plan" for Bio-economy Development issued by the National Development and Reform Commission clarified that vigorously consolidating the foundation of bio-economy innovation, cultivating and expanding the pillar industries of the bio-economy, actively promoting the protection and utilization of biological resources, and accelerating the construction of a bio-safety guarantee syst.
Efforts will be made to optimize five specific tasks in the biological field, including the policy environme.
Among them, in terms of cultivating and expanding the pillar industries of the bio-economy, the plan also proposes to select and breed a batch of Chinese herbal medicines, strengthen the quality assurance of Chinese herbal medicines from the source, promote the transformation and upgrading of the traditional Chinese herbal medicine planting industry, and establish an ecological planting system of Chinese herbal medicin.
Develop a batch of high-quality traditional Chinese medicine, support the standardization of traditional Chinese medicine, and build a library of traditional Chinese medicine reference materials, a quality control standard system, and an information and data platfo.
Driven by national policies, various localities are paying more and more attention to the development of the Chinese herbal medicine industry, and they have begun to accelerate the release of development plans and measures related to the cultivation and processing of Chinese herbal medicines to promote the standardized and large-scale cultivation of Chinese herbal medicines and improve the quality of Chinese herbal medicin.
For example, not long ago, the Department of Agriculture and Rural Affairs of Heilongjiang Province issued the "2022 Work Plan for the Development of Chinese Medicinal Materials Industry in Heilongjiang Province" (hereinafter referred to as the "Plan"), which will be specific to the development goals, work priorities, and work measures of the province's Chinese medicinal materials industry this ye.
Depl.
In addition, the Hunan Provincial Administration of Traditional Chinese Medicine, the Provincial Drug Administration, and the Provincial Health and Health Commission also jointly issued "Several Measures for Promoting the High-quality Development of the Traditional Chinese Medicine Industry in Hunan Province" on April 8 (hereinafter referred to as "Several Measures".
The "Several Measures" put forward 12 policies and measures around the quality brand of Chinese herbal medicines produced in Hunan, the research and development, processing, production of Chinese herbal medicines, and Chinese medicine skilled talen.
Production, processing, storage, e.
will become more and more standardized, and the quality of Chinese herbal medicine products will also continue to impro.
The industry believes that this will play an important role in boosting the development of Chinese herbal medicine product brands and related enterprises in China, and further enhance industrial efficien.
In fact, as the Chinese herbal medicine industry continues to develop in a healthier and high-quality direction, relevant companies have begun to usher in more opportunities through continuous explorati.
Taking Zhendong Pharmaceutical as an example, it already has the advantages of the whole industrial chain of Chinese medicinal materials integrating seed and seedling tending, planting, processing, warehousing and decoction piec.
The company implements "government guidance + enterprise technical services and investment + cooperative organization management + farmers The planting model of "operation" is vigorously developing the production and processing base of high-quality medicinal materia.
It is understood that in 2021, the Chinese herbal medicine sector of Zhendong Pharmaceutical will achieve annual sales revenue of 639 million yuan, a year-on-year increase of 42
Under the severe epidemic situation, more than 30 varieties of Forsythia, Scutellaria, Polygala Radix, Rehmannia glutinosa, e.
have been exported to Taiwan, Vietnam, Indonesia, Malaysia and other countries and regio.
Analysts said that Zhendong Pharmaceutical already has development advantages in the field of traditional Chinese medicinal materials, and the company will benefit from the development of the traditional Chinese medicine industry in the futu.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
In order to promote the high-quality development of the Chinese herbal medicine industry, the state has issued a series of policies and measures that are being introduc.
For example, in March this year, the "Quality Management Standards for the Production of Chinese Herbal Medicines" (Chinese Herbal Medicine GAP), which was researched and formulated by the State Food and Drug Administration, the Ministry of Agriculture and Rural Affairs, the State Forestry and Grass Administration, and the State Administration of Traditional Chinese Medicine, proposed that it will encourage Chinese herbal medicine production enterprises, Traditional Chinese medicine production enterprises such as the holder of the marketing license for proprietary Chinese medicines shall establish themselves in the production areas of Chinese herbal medicines, and jointly build Chinese herbal medicine production enterprises and production bases that comply with this specification, and extend the drug quality management system to the production areas of Chinese herbal medicin.
Recently, the "14th Five-Year Plan" for Bio-economy Development issued by the National Development and Reform Commission clarified that vigorously consolidating the foundation of bio-economy innovation, cultivating and expanding the pillar industries of the bio-economy, actively promoting the protection and utilization of biological resources, and accelerating the construction of a bio-safety guarantee syst.
Efforts will be made to optimize five specific tasks in the biological field, including the policy environme.
Among them, in terms of cultivating and expanding the pillar industries of the bio-economy, the plan also proposes to select and breed a batch of Chinese herbal medicines, strengthen the quality assurance of Chinese herbal medicines from the source, promote the transformation and upgrading of the traditional Chinese herbal medicine planting industry, and establish an ecological planting system of Chinese herbal medicin.
Develop a batch of high-quality traditional Chinese medicine, support the standardization of traditional Chinese medicine, and build a library of traditional Chinese medicine reference materials, a quality control standard system, and an information and data platfo.
Driven by national policies, various localities are paying more and more attention to the development of the Chinese herbal medicine industry, and they have begun to accelerate the release of development plans and measures related to the cultivation and processing of Chinese herbal medicines to promote the standardized and large-scale cultivation of Chinese herbal medicines and improve the quality of Chinese herbal medicin.
For example, not long ago, the Department of Agriculture and Rural Affairs of Heilongjiang Province issued the "2022 Work Plan for the Development of Chinese Medicinal Materials Industry in Heilongjiang Province" (hereinafter referred to as the "Plan"), which will be specific to the development goals, work priorities, and work measures of the province's Chinese medicinal materials industry this ye.
Depl.
In addition, the Hunan Provincial Administration of Traditional Chinese Medicine, the Provincial Drug Administration, and the Provincial Health and Health Commission also jointly issued "Several Measures for Promoting the High-quality Development of the Traditional Chinese Medicine Industry in Hunan Province" on April 8 (hereinafter referred to as "Several Measures".
The "Several Measures" put forward 12 policies and measures around the quality brand of Chinese herbal medicines produced in Hunan, the research and development, processing, production of Chinese herbal medicines, and Chinese medicine skilled talen.
Production, processing, storage, e.
will become more and more standardized, and the quality of Chinese herbal medicine products will also continue to impro.
The industry believes that this will play an important role in boosting the development of Chinese herbal medicine product brands and related enterprises in China, and further enhance industrial efficien.
In fact, as the Chinese herbal medicine industry continues to develop in a healthier and high-quality direction, relevant companies have begun to usher in more opportunities through continuous explorati.
Taking Zhendong Pharmaceutical as an example, it already has the advantages of the whole industrial chain of Chinese medicinal materials integrating seed and seedling tending, planting, processing, warehousing and decoction piec.
The company implements "government guidance + enterprise technical services and investment + cooperative organization management + farmers The planting model of "operation" is vigorously developing the production and processing base of high-quality medicinal materia.
It is understood that in 2021, the Chinese herbal medicine sector of Zhendong Pharmaceutical will achieve annual sales revenue of 639 million yuan, a year-on-year increase of 42
Under the severe epidemic situation, more than 30 varieties of Forsythia, Scutellaria, Polygala Radix, Rehmannia glutinosa, e.
have been exported to Taiwan, Vietnam, Indonesia, Malaysia and other countries and regio.
Analysts said that Zhendong Pharmaceutical already has development advantages in the field of traditional Chinese medicinal materials, and the company will benefit from the development of the traditional Chinese medicine industry in the futu.
Disclaimer: Under no circumstances does the information or opinions expressed in this article constitute investment advice to anyo.
